Literature DB >> 29223545

The bowel function and quality of life of Hirschsprung disease patients who have reached 18 years of age or older - the long-term outcomes after undergoing the transabdominal soave procedure.

Shun Onishi1, Kazuhiko Nakame1, Tatsuru Kaji1, Masato Kawano1, Tomoe Moriguchi1, Koshiro Sugita1, Keisuke Yano1, Mioko Nomura1, Koji Yamada1, Waka Yamada1, Ryuta Masuya1, Takafumi Kawano1, Seiro Machigashira1, Motoi Mukai1, Satoshi Ieiri2.   

Abstract

BACKGROUND/
PURPOSE: Hirschsprung disease (HD) is considered curable, but the postoperative bowel function is not always satisfactory. In this study, we evaluated the general condition, bowel function, and social performance in adults who were older than 17years of age who had undergone definitive operations in childhood.
METHOD: From 1984 to 2016, 110 patients with HD underwent definitive surgery at our institute. Sixty-three patients who had undergone the transabdominal Soave procedure reached 18years of age. Their present status and symptoms, anorectal function, genitourinary function, and social performance were evaluated during the clinical follow-up via a questionnaire survey. RESULT: The mean age of the questionnaire respondents was 25.0 (19-37) years. The bowel function was mostly good. However, 56% of patients had abdominal pain more than once a week. Regarding evacuation symptoms, incontinence and soiling occurred in 18.7%. Among the respondents 33.3% were married, and 60% of those who were married had children. The respondents had achieved success in their education and professional careers.
CONCLUSION: The bowel function of most patients was satisfactory, although some had chronic abdominal symptoms. Pediatric surgeons should continue trying to achieve complete bowel function after definitive surgery of HD. TYPE OF STUDY: Prospective Cohort Study. LEVEL OF EVIDENCE: Level III.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Adulthood; Bowel function; Hirschsprung disease; Long-term outcome; Quality of life; Soave procedure

Mesh:

Year:  2017        PMID: 29223545     DOI: 10.1016/j.jpedsurg.2017.08.036

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  High Levels of Interest in Reproductive Genetic Information in Parents of Children and Adults With Hirschsprung Disease.

Authors:  Courtney D Berrios; Aravinda Chakravarti; Barbara B Biesecker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 2.  ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease.

Authors:  Kristiina Kyrklund; Cornelius E J Sloots; Ivo de Blaauw; Kristin Bjørnland; Udo Rolle; Duccio Cavalieri; Paola Francalanci; Fabio Fusaro; Annette Lemli; Nicole Schwarzer; Francesco Fascetti-Leon; Nikhil Thapar; Lars Søndergaard Johansen; Dominique Berrebi; Jean-Pierre Hugot; Célia Crétolle; Alice S Brooks; Robert M Hofstra; Tomas Wester; Mikko P Pakarinen
Journal:  Orphanet J Rare Dis       Date:  2020-06-25       Impact factor: 4.123

3.  Quality of life of patients with Hirschsprung disease after Duhamel and Soave pull-through procedures: A mixed-methods sequential explanatory cohort study.

Authors:  Michelle Raj Saysoo; Fatwa Sari Tetra Dewi
Journal:  Ann Med Surg (Lond)       Date:  2020-06-12

4.  OBLIQUE VS. CIRCULAR ANASTOMOSIS IN THE CHILDREN UNDERWENT SOAVE'S PULL-THROUGH SURGERY FOR THE TREATMENT OF HIRSCHSPRUNG'S DISEASE: WHICH IS THE BEST?

Authors:  Shahnam Askarpour; Mehran Peyvasteh; Gholamreza Droodchi; Hazhir Javaherizadeh
Journal:  Arq Bras Cir Dig       Date:  2021-01-15

5.  Assessment of Quality of Life and Functional Outcomes of Operated Cases of Hirschsprung Disease in a Developing Country.

Authors:  Arun Kumar Loganathan; Aleena Sara Mathew; Jujju Jacob Kurian
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.